Sign inJoin waitlistJoin the waitlist

Christopher Sayed

Physician · University of North Carolina School of Medicine

Credentials: · · ·

History

University of North Carolina School of Medicine
Present

Gastroenterology
University of North Carolina at Chapel Hill, 2012-2013
2013–2016
Dermatology
University of North Carolina School of Medicine
2010–2013
University of North Carolina Hospitals
2009–2010
University of North Carolina at Chapel Hill, 2012-2013
University of North Carolina at Chapel Hill School of Medicine
2005–2009

Research

North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part II:…
Review · Journal of the American Academy of Dermatology · 2019 · 290 citations
North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I:…
Review · Journal of the American Academy of Dermatology · 2019 · 277 citations
Evaluating patients' unmet needs in hidradenitis suppurativa: Results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project
Journal of the American Academy of Dermatology · 2020 · 251 citations

JH
Jennifer Hsiao
17 papers
Afsaneh Alavi
16 papers
ML
Michelle Lowes
15 papers
Amit Garg
14 papers
Haley Naik
14 papers
Iltefat Hamzavi
13 papers
Linnea Westerkam
13 papers · 5 as a resident
Noah Goldfarb
12 papers
Vivian Shi
12 papers · 2 as a fellow
JF
John Frew
11 papers
RS
Rayad Shams
11 papers · 1 as a resident
SD
Steve Daveluy
11 papers

Grants

Determining the Genetic Basis of Hidradenitis Suppurativa
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R01
Contact PI · $1.3M · Univ of North Carolina Chapel Hill
2024–2029
Evaluation of the Genetics of Hidradenitis Suppurativa
National Institute of Arthritis and Musculoskeletal and Skin Diseases · R21
Contact PI · $305.5K · Univ of North Carolina Chapel Hill
2020–2023

Clinical trials

Mediterranean Dietary Intervention for HS
Principal investigator · Not yet recruiting
University of North Carolina, Chapel Hill
2026–2027
Anifrolumab for Hidradenitis Suppurativa
Principal investigator · Completed · Phase 2
University of North Carolina, Chapel Hill
2024–2026
A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.
Principal investigator · Completed
University of North Carolina, Chapel Hill
2016–2017
Wet-to-dry vs Petrolatum & Non-stick Dressings After Hidradenitis Suppurativa Surgery
Study director · Completed
University of North Carolina, Chapel Hill
2022–2023